Update your tester profile Login
  • Register with Our Database

    Get started on the volunteer process by registering your basic information with our database. This information is provided to help us determine your eligibility for current and future studies. We will not share or sell this info with any third party. 

    Thanks for your interest, you'll find the intake form here

  • Research Study 1602: Healthy Male and Female Participants

    Research Purpose:  Study 1602 is designed to evaluate three different oral formulations of an investigational drug being developed for the treatment of human rhinovirus.  The following will be evaluated:

    • How each of the three formulations of the investigational drug impacts the body.
    • The safety/tolerability of the investigational drug

     

    Minimum Screening Qualifications:

    Males

    Men are allowed to participate

    Females

    Only Women who are not breastfeeding, pregnant, or planning to become pregnant are allowed to participate. 

    Age

    19-60 years

    Body Mass Index (BMI)

    18 to 32

    Weight

    Must weigh greater or equal to 110 pounds

    Tobacco/Nicotine Use

    Must be able and willing to abstain from tobacco/nicotine and electronic cigarettes 14 days before the start of the study until the final study visit. 

    Drug Testing

    Must test negative for drugs of abuse. 

    Substance Abuse History

    No history of drug or alcohol abuse within 2 years before the start of the study

    Health History

    Must be healthy; not being evaluated or treated for any medical conditions unless otherwise approved on a case by case basis by the study doctor

    Restricted Medications

    • No chronic use of any prescription medications in the 90 days prior to the start of the study through the final study visit
    • No over-the-counter medications, supplements, or vitamins 7 days prior to the start of the stud through the final study visit.

     

    Study Time Commitment: For participants who qualify based on screening evaluation, study participation will last for approximately 3 and a half weeks. 

    In-house Stays

    Participants will stay at Prism Clinical Research three times. 

    • Each in-house stays will last approximately 60 hours (2 overnights)
    • The in-house stays will be separated by approximately one week

    Study Visits

    The third in-house stay is followed by one brief study visit.

     

    Compensation: Up to $1,885.00 for study participation time.

     

     

     

     
       

     


    For information regarding this study contact Sarah: 651-368-3360 or sarahl@prismresearchinc.com

  • Study 1321: Healthy Participants

    Research Purpose:  Study 1321 is designed to evaluate an investigational drug being developed for the treatment of certain types of inflammatory disorders. The investigational drug will be given orally to healthy participants.  The purpose of the study is to determine how much of the investigational drug enters the blood stream when given at different dose levels; whether having an empty or full stomach affects how much of the investigational drug enters the blood stream; and how well the body tolerates the investigational drug.

    Screening Qualifications: Participants must meet the following minimum criteria in order to qualify for a screening appointment:

    • Age 18-55 years
    • Body Mass Index (BMI) between 18-32
    • Must be healthy; not being evaluated or treated for any medical conditions.
    • Cannot take medications on a regular basis (Exception: women can be using an prescribed hormonal birth control)
    • No history of cancer (Exception: cured basal or squamous cell skin cancers)
    • No history of drug addiction or alcoholism 12 months prior to the screening appointment
    • No use of more than the equivalent of 5 cigarettes per week in the two months before the screening appointment.
    • Must be able and willing to refrain from use of tobacco or nicotine containing products one week before the study starts until the end of the study
    • Must be able and willing to eat/drink a study specific meal which includes pork, eggs, dairy, and gluten.

    Study Time Commitment: For participants who qualify for the study based on screening results, study participation will last for approximately 3 ½ weeks.  During that time, participants will stay at Prism Clinical Research for three short inpatient stays lasting approximately 72 hours (three overnights) each time.  The inpatient stays will be separated by one week.  There will be one brief outpatient visit following the final inpatient stay. 

    Compensation: up to $2550 for participation time 

  • Study 1615: Healthy Male and Female Particpants

    Research Purpose: Study 1615 is designed to compare an investigational drug being developed for the treatment Attention-Deficit Hyperactivity Disorder (ADHD) to an approved medication currently available for treatment of the same condition. Participants will receive a single dose of the investigational drug and the FDA approved medication on two in clinic stays. The following will be evaluated:

    • How quickly the body processes and eliminates the investigational drug and the FDA approved drug
    • The general safety and tolerability of the investigational drug

     

    Minimum Screening Qualifications:

    Males

    Men are allowed to participate.

    Females

    Women are allowed to participate

    Age

    18-55 years

    Body Mass Index (BMI)

    Between 18-32 kg/m²

    Drug Testing

    Must test negative for drugs of abuse. 

    Alcohol/Drug Abuse

    History

    No history of drug or alcohol abuse within 1 year before the screening appointment.

    Health History

    • No history of ADHD
    • Must be healthy; not being evaluated or treated for any medical conditions unless otherwise approved on a case by case basis by the study doctor

    Restricted Medications

    Subject agrees to abstain from taking any dietary supplements, vitamins, herbal medications, antacids, prescription drugs (other than hormonal birth control) or non-prescription drugs taken for non-therapeutic indications, except as authorized by the study doctor

     

    Allowed Medications

    Prescribed, stable hormonal birth control is allowed

     

    Study Time Commitment: For participants who qualify based on screening evaluation, study participation will last for approximately 6 weeks which includes the screening period.

    Inpatient Stays

    • Participants will admit for an in clinic stay at Prism Clinical Research 2 times.
    • The in clinic stays will last approximately 60 hours (2 overnights each)

    Outpatient Visits

    • There is one outpatient visit lasting approximately 90 minutes.

     

    Compensation: Up to $1325.00

  • Non-Drug Studies

    New Non-Drug Study Opportunities Now Available Through Prism Research!

     

    Prism Research is proud to announce that we are now recruiting for non-drug studies!  You or someone you know might be qualified to participate in these studies.

     

    What are Non-Drug Studies?

    Medical devices like auto-injection pens, inhalers, and breast pumps must go through testing before they can be made available to the public.  In Non-Drug Studies, participants will simulate use of a medical device and provide feedback to how easy it was to use the device.  Just like drug-studies, participants receive financial compensation for their time

     

    Who can participate in Non-Drug Studies?

    Anyone who meets the qualifications for a specific study can participate and there will be many future opportunities.  Right now, we are specifically looking for the following people for multiple studies throughout the spring and summer:

     

    • People diagnosed with Rheumatoid Arthritis
    • Caregivers for people with Rheumatoid Arthritis

     

    Email a recuriter or call 651-289-2096 for more info!

Where hope, science & understanding meet.

From the aspirin on the shelves of your local drugstore, to the insulin prescribed by a doctor, to the pacemaker keeping someone’s heart on track – all have been subject to clinical trials, and integral part of the Food and Drug Administration (FDA) approval process.

A critical step in an important process

Drugs and medical devices undergo years of laboratory testing before they reach the clinical trial phase. Researchers must acquire approval from the FDA for approval to continue research and testing in humans. Clinical trials are essential to measure the efficacy and safety of drugs before they are available for widespread use.

Changing lives, every day.

The impact of clinical trials are seen in our everyday lives, in the confidence with which we can take over-the-counter drugs – or in the life-saving benefits of a breakthrough medication for a victim of Leukemia.

Public Health and Safety

Prior to the development of the FDA’s rigorous and highly regulated method, consumers had to rely upon the anecdotal observation of physicians or spurious claims of pharmacists. In 1906, in order to protect public health and safety, the fledgling FDA passed the first regulatory drug act – the Pure Food and Drug Act.

In 1938, the enactment of the U.S. Food, Drug, and Cosmetic Act subjected new drugs to pre-market safety evaluation for the first time, thus enabling FDA regulators to review both pre-clinical and clinical test results, giving them the authority to block the marketing of a new drug formally or delay it by requiring additional data.

Alongside the evolving standards of drug regulations, closer regulation of the clinical trial process. The resulting process today is designed to protect the safety of study participants, promote the development of lifesaving drugs, and keep public health and safety at the center of medical advancement. In the century since the first drug act, the research and medical community in cooperation with the FDA, have developed the foremost institutional authority for conducting and evaluating controlled clinical drug trials.

Doing the right thing

Know that you’ve done your part to help make important medications available to those who need them. If you have a friend or family member who relies on a medication to treat a chronic disease or illness, they have benefited from the work of a clinical trial, and a volunteer like you who gave their time and effort to aid in the approval process.

Fair compensation for your time

You’ll be compensated based on the time you spend as a study participant.

Medical exam & monitoring

As a study participant, you’ll likely receive a full medical examination and testing for a variety of conditions. In some cases volunteers might have access to treatments or medicines before they are available to the general population.

Changing lives, advancing science, furthering the reach of medicine.

Prism Clinical Research provides, FDA approved, investigational pharmaceutical and medical device testing services on behalf of drug and device manufacturers, academic and private physicians as well as other researchers across Minnesota.

Icon 05

At Prism, we are committed to the advancement of medical knowledge and the health of our community. We have been conducting Phase I clinical trials since 2005, helping many important drugs reach FDA approval. Prism is a locally owned and operated, independent facility in the heart of the Minneapolis/St. Paul metropolitan area. 

Whether you are here because you are interested in participating in a clinical trial, or you’re searching for a trusted partner to conduct a study on your behalf, our hope is that you find the information you need and the confidence to take the next step. 

With your help, we can make a difference.


Learn what Prism Volunteers are saying:

Volunteer Large 13

"I am VERY pleased with Prism Research. I enjoy the studies and the staff is always friendly and they all make you feel as comfortable as possible. The study compensation program is very good as well! Thank you."

  • Volunteers 08

    “Concerned enough to ask questions. I enjoy visiting with the staff. I look forward to future studies and may qualify to participate in.”

  • Volunteers 05

    “Overall you do a great job! Your staff is very friendly and accommodating. Your facility is very comfortable. Thanks!”

  • Volunteers 06

    “Staff was courteous and well informed of the nature of the study and all of the requirements that went with it.”

  • Volunteers 07

     “Overall my experiences at Prism have been very positive and directly linked to the Staff - their demeanor, humor and professional approach.”


Please provide us with your contact information (below) and will get back to you as soon as possible.

If you have a general question, check Volunteer FAQ for an answer. If you're unsure of who to contact, please visit the Contact Us page.

Cancel